Nectar Lifesciences Limited (NECLIFE) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE023H01027
Key metrics
- Market Cap
- ₹243 Cr
- P/E Ratio
- —
- EPS
- -3.6
- Book Value
- 29.97
- P/B Ratio
- 0.44
- ROE
- -50.3%
- ROCE
- -5%
- Debt / Equity
- —
- Net Margin
- —
- Revenue Growth
- —
- Profit Growth
- -157.64%
- Dividend Yield
- —
- 52W High
- ₹22.40
- 52W Low
- ₹9.30
- Market Cap Band
- micro cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Nectar Lifesciences Limited
Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Further. It exports its poducts. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
- Headquarters
- Chandigarh, India
- Employees
- 111
- Promoter Holding
- 55.66%
The full Nectar Lifesciences Limited analysis
Create a free account to open the complete NECLIFE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.